Guy Ezekiel - Brainsway President CEO
| BRIN Stock | 960.00 5.10 0.53% |
CEO
Dr. Guy Ezekiel will no longer serve as President Chief Executive Officer and Director at Brainsway Ltd effective July 28 2016. He has held this role since November 23 2015. Prior to this he served as President and Chief Executive Officer at the Company since June 15 2015. His work experience includes the following roles Board Member at Realview Imaging from 2014 Board Member at Enopace from 2013 Board Member at BGN Technologies from 2009 Chairman of the Board President and Chief Executive Officer at Maval Pharma between 2009 and March 2015 General Manager and Vice President of Innovation at Medtronic between 2009 and June 2012 and Board Member President and Chief Executive Officer at Ventor Technologies between 2006 and 2009. He holds a Doctorate of Medicine degree from Ben Gurion University and a MBA degree from University of Pittsburgh.
| Age | 45 |
| Professional Marks | MBA |
| Phone | 972 2 5813140 |
| Web | www.brainsway.com |
Similar Executives
| Showing other executives | CEO Age | ||
| Alon Agoshbitz | Analyst IMS Investment | 49 | |
| Nurit Tvito | YH Dimri Construction | 50 | |
| Amir Hessel | Harel Insurance Investments | 50 | |
| Ari Bronshtein | Elron Electronic Industries | 47 | |
| Adi Dana | Isras Investment | 49 | |
| Tal Kedem | Harel Insurance Investments | 49 | |
| Michel Siboni | Harel Insurance Investments | 64 | |
| Itzhak Shenidovski | Analyst IMS Investment | 42 | |
| Eyal Lewin | Insuline Medical | 51 | |
| Yoav Manor | Harel Insurance Investments | 62 | |
| Ronen Agassi | Harel Insurance Investments | 47 | |
| Shmuel Babecov | Harel Insurance Investments | 53 | |
| Yechezkel Dimri | YH Dimri Construction | 29 | |
| Tzur Peleg | Analyst IMS Investment | 44 | |
| Ofer Lotan | Analyst IMS Investment | 49 | |
| Ilana Primo | Analyst IMS Investment | 58 | |
| Yigal Dimri | YH Dimri Construction | 67 | |
| Aviv Seges | YH Dimri Construction | 38 | |
| Shai Tauber | Isras Investment | 61 | |
Brainsway Leadership Team
Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gavriel Magen, Director | ||
| Avraham Posen, Director of Global Sales | ||
| Uri Elmaliach, Director | ||
| Rami Itselev, Internal Auditor | ||
| Daniel Azriel, Director | ||
| Karen Sarid, Director | ||
| David Zacut, Chairman of the Board | ||
| Ety Rayten, External Director | ||
| Daniel Azriely, Director | ||
| Yuval Lavi, Director | ||
| Amit Jino, Clinical Experiment Coordinator | ||
| Hila Rubinshtein, Managing Director of Quality Control | ||
| Giora Yanay, Director | ||
| Ofra Hackelman, COO | ||
| Yosef Shalom, Director | ||
| Avner Hagai, Founder and President and Director | ||
| Yiftach Roth, Founder, Chief Scientist and Director | ||
| Yael Ziger, CFO | ||
| Orly Uri, External Director | ||
| Ronen Segal, VP of RandD | ||
| Guy Ezekiel, President CEO | ||
| Yaacov Michlin, Director | ||
| Eynat Tsafrir, External Director |
Brainsway Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| EBITDA | (3.89 M) | |||
| Cash And Equivalents | 9.07 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 2.83 M | |||
| Debt To Equity | 40.70 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | (3.77 M) | |||
| Earnings Per Share | (0.39) X | |||
| Number Of Employees | 96 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brainsway in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brainsway's short interest history, or implied volatility extrapolated from Brainsway options trading.
Pair Trading with Brainsway
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainsway position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will appreciate offsetting losses from the drop in the long position's value.Moving against Brainsway Stock
| 0.49 | APLY | Aerodrome Group | PairCorr |
The ability to find closely correlated positions to Brainsway could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainsway when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainsway - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainsway to buy it.
The correlation of Brainsway is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainsway moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainsway moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainsway can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |